Proteomic analysis of the effects of baicalein on colorectal cancer cells

Proteomics

Volumn 12, Issue 6, 2012, Pages 810-819

  Huang, Wen Shih ^a,b   Kuo, Yi Hung ^a,b   Chin, Chih Chien ^a,b   Wang, Jeng Yi ^a   Yu, Hong Ren ^a,b   Sheen, Jiunn Ming ^a,b   Tung, Shui Yi ^b   Shen, Chien Heng ^b   Chen, Te Chuan ^b   Sung, Mei Lan ^c,d   Liang, Hwey Fang ^c   Kuo, Hsing Chun ^c,d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d CGUST   (Taiwan)

Author keywords

Baicalein; Cell biology; Colorectal cancer cells; MALDI TOF TOF; Proteomic differential displays; Reactive oxygen species

Indexed keywords

BAICALEIN; PEROXIREDOXIN 6; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CELLULAR DISTRIBUTION; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; CYTOLOGY; DIFFERENTIAL DISPLAY; DRUG EFFECT; DRUG TARGETING; EPITHELIUM CELL; GENE SILENCING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEOMICS; UPREGULATION;

ANTIOXIDANTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FLAVANONES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; PEROXIREDOXIN VI; PROTEOME; PROTEOMICS; REACTIVE OXYGEN SPECIES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84860331563     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100270     Document Type: Article

References (30)

1. Jemal, A., Siegel, R., Xu, J., Ward, E. et al., Cancer statistics. CA Cancer J. Clin. 2010, 60, 277-300.
2. Surh, Y. J., Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 2003, 3, 768-780.
3. Weng, C. J., Yen, G. C., Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat. Rev. 2011, 38, 76-87.
4. Kris-Etherton, P. M., Hecker, K. D., Bonanome, A., Coval, S. M. et al., Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 2002, 113, 71S-88S.
5. Havsteen, B., Flavonoids, a class of natural products of high pharmacological potency. Biochem. Pharmacol. 1983, 32, 1141-1148.
6. Di Carlo, G., Mascolo, N., Izzo, A. A., Capasso, F., Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci. 1999, 65, 337-53.
7. Chen, C., Kong, A. N., Dietary chemopreventive compounds and ARE/EpRE signaling. Free Radic. Biol. Med. 2004, 36, 1505-1516.
8. Li-Weber, M., New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat. Rev. 2009, 35, 57-68.
9. Gao, J., Morgan, W. A., Sanchez-Medina, A., Corcoran, O., Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway. Toxicol. Appl. Pharmacol. 2010, 112, 1500-1512.
10. Kuo, H. C., Lee, H. J., Hu, C. C., Shun, H. I. et al., Enhancement of esculetin on taxol-induced apoptosis in human hepatoma HepG2 cells. Toxicol. Appl. Pharmacol. 2006, 210, 55-62.
11. Lin, T. H., Kuo, H. C., Chou, F. P., Lu, F. J., Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer. 2008, 8, 58.
12. Lee, H. J., Wang, C. J., Kuo, H. C., Chou, F. P. et al., Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK. Toxicol. Appl. Pharmacol. 2005, 203, 124-131.
13. Kuo, H. C., Kuo, W. H., Lee, Y. J., Lin, W. L. et al., Inhibitory effect of caffeic acid phenethyl ester on the growth of C6 glioma cells in vitro and in vivo. Cancer Lett. 2006, 234, 199-208.
14. Kuo, H. C., Chiu, C. C., Chang, W. C., Sheen, J. M. et al., Use of proteomic differential displays to assess functional discrepancies and facilitate adjustments of different human mesenchymal stem cell types. J. Proteome Res. 2011, 10, 1305-1315.
15. Yu, H. R., Kuo, H. C., Huang, H. C., Kuo, H. C. et al., Identification of immunodeficient molecules in neonatal mononuclear cells by proteomic differential displays. Proteomics 2011, 11, 3492-3500.
16. Chiu, Y. W., Lin T. H., Huang, W. S., Teng, C. Y. et al., Baicalein inhibits the migration and invasive properties of human hepatoma cells. Toxicol. Appl. Pharmacol. 2011, 255, 316-326.
17. Huang, W. S., Chin, C. C., Chen, C. N., Kuo, Y. H., et al., Stromal cell-derived factor-1/CXC receptor 4 and β1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells. J. Cell. Physiol. 2012, 227, 1114-1122.
18. Nurse, P., A long twentieth century of the cell cycle and beyond. Cell 2000, 100, 71-78.
19. Berger, J. H., Bardeesy, N., Modeling INK4/ARF tumor suppression in the mouse. Curr. Mol. Med. 2007, 7, 63-75.
20. Piao, Y. S., Du, Y. C., Oshima1, H., Jin, J. C. et al., Platelet-type 12-lipoxygenase accelerates tumor promotion of mouse epidermal cells through enhancement of cloning efficiency. Carcinogenesis 2008, 29, 440-447.
21. Po, L. S., Chen, Z. Y., Tsang, D. S., Leung, L. K., Baicalein and genistein display differential actions on estrogen receptor (ER) transactivation and apoptosis in MCF-7 cells. Cancer Lett. 2002, 187, 33-40.
22. Chao, J. I., Su, W. C., Liu, H. F., Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT. Mol. Cancer Ther. 2007, 6, 3039-3048.
23. Kuo, H. M., Tsai, H. C., Lin, Y. L., Yang, J. S. et al., Mitochondrial-dependent caspase activation pathway is involved in baicalein-induced apoptosis in human hepatoma J5 cells. Int. J. Oncol. 2009, 35, 717-724.
24. Sánchez-Martín, D., Cuesta, A. M., Fogal, V., Ruoslahti, E. et al., The multicompartmental p32/gClqR as a new target for antibody-based tumor targeting strategies. J. Biol. Chem. 2011, 286, 5197-5203.
25. Jacob Blackmon, B., Dailey, T. A., Lianchun, X., Dailey, H. A., Characterization of a human and mouse tetrapyrrole-binding protein. Arch. Biochem. Biophys. 2002, 407, 196-201.
26. Nigar, F., Eri, K., Yoshihiro, T., Keiichi, I. et al., Loss of NF-κB control and repression of PRDX6 gene transcription by reactive oxygen species-driven SMAD3-mediated transforming growth factor β signaling. J. Biol. Chem. 2002, 284, 22758-22772.
27. Giles, G. I., The redox regulation of thiol dependent signaling pathways in cancer. Curr. Pharm. Des. 2006, 12, 4427-4443.
28. Szatrowski, T. P., Nathan, C. F., Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991, 51, 794-798.
29. Benhar, M., Dalyot, I., Engelberg, D., Levitzki, A., Enhanced ROS production in oncogenically transformed cells potentiates C-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol. Cell. Biol. 2001, 21, 6913-6926.
30. Kim, S. Y., Jo, H. Y., Kim, M. H., Cha, Y. Y. et al., H2O2-dependent hyperoxidation of peroxiredoxin 6 (PRDX6) plays a role in cellular toxicity via up-regulation of iPLA2 activity. J. Biol. Chem. 2008, 283, 33563-33568.